Humana Inc Intrinsic Stock Value – HUMANA INC Reports Total Revenue Decrease of 7.1% and Net Income Increase of 6.6% for Fiscal Year 2022.

February 20, 2023

Earnings report

HUMANA INC ($NYSE:HUM), one of the largest healthcare networks in the United States, recently released their fiscal year 2022 results. On December 31 2022, HUMANA INC reported their earnings results for the fourth quarter of their fiscal year 2022, ending February 1 2023. These results showed a decrease in total revenue from the same period the year prior, with a 7.1% decrease to -$15.0 million.

However, the company did report an increase in net income, to $22439.0 million, a 6.6% increase from the previous year. These financial results demonstrate that HUMANA Inc is continuing its effort in providing excellent care to its members and increasing their overall value. Despite the decrease in total revenue, the company showed a growth in net income, indicating that their fiscal initiatives have been successful thus far.

Stock Price

HUMANA INC reported a total revenue decrease of 7.1% for the fiscal year of 2022, compared to its previous year. Despite this decrease in revenue, the company showed an increase in net income of 6.6%, signaling a strengthening of the company’s financial standing. On Wednesday, HUMANA INC stock opened at $506.1 and closed at $513.3, representing a rise of 0.3% from the prior closing price of 511.7. This increase in share price reflects a confidence in the company and its outlook for future profits. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Humana Inc. More…

    Total Revenues Net Income Net Margin
    92.87k 2.81k 2.8%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Humana Inc. More…

    Operations Investing Financing
    4.59k -1.01k -1.91k
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Humana Inc. More…

    Total Assets Total Liabilities Book Value Per Share
    43.05k 27.68k 122.51
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Humana Inc are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    12.7% 4.3%
    FCF Margin ROE ROA
    3.7% 15.7% 5.8%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis – Humana Inc Intrinsic Stock Value

    At GoodWhale, we recently conducted an analysis of HUMANA INC‘s wellbeing. We used our proprietary Valuation Line to compute the intrinsic value of HUMANA INC’s share, which came out to be around $497.5. Taking a look at the market prices currently, we observe that HUMANA INC’s stock is being traded at $513.3, an amount that is a fair price but slightly overvalued by 3.2%. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • Peers

    In the ever-changing world of healthcare, Humana Inc. has been a leader in providing quality services to its customers. However, the company faces stiff competition from the likes of UnitedHealth Group Inc, Cigna Corp, and Oscar Health Inc. All of these companies are striving to provide the best possible healthcare experience to their customers.

    – UnitedHealth Group Inc ($NYSE:UNH)

    UnitedHealth Group Inc. is an American for-profit managed health care company based in Minnetonka, Minnesota. It is the largest healthcare company in the world by revenue, with 2019 revenue of $242.2 billion. The company offers health care products and services through two operating businesses: UnitedHealthcare and Optum.

    UnitedHealthcare provides health benefits and services to individuals, families, and businesses through a wide array of plans and programs, including health insurance, pharmacy benefits, vision, dental, and other supplemental health and wellness benefits. Optum is a health services and innovation company that provides technology-enabled health services and software. It offers healthcare information technology, data analytics, and research and consulting services to the healthcare industry.

    The company has a market capitalization of $488.16 billion as of April 2021 and a return on equity of 21.75%.

    – Cigna Corp ($NYSE:CI)

    Cigna Corp is a health services company with a market cap of 88.46 billion as of 2022. The company has a return on equity of 11.01%. Cigna Corp provides medical, dental, disability, life, and other health insurance products and services. The company also offers pharmacy benefit management services.

    – Oscar Health Inc ($NYSE:OSCR)

    Oscar Health is a technology-driven health insurance company founded in 2012. The company’s mission is to make health insurance simple, transparent, and human.

    Oscar uses technology to simplify the health insurance experience for consumers and providers. The company has a suite of tools that helps consumers understand their benefits, find doctors, and estimate the cost of care. For providers, Oscar offers a platform that streamlines claims processing and provides real-time insights into patients’ health insurance benefits.

    Oscar Health is headquartered in New York City and is available in nine states: California, Colorado, Florida, Georgia, Illinois, Michigan, New Jersey, New York, and Texas.

    Summary

    Humana Inc. released their financial results for the previous year, reporting a total revenue of -$15.0 million, representing a 7.1% decrease from the same period the year prior. Despite this drop in revenue, the company’s net income was $22439.0 million, which was 6.6% higher than the previous year. Overall, this could be seen as a positive sign for investors, as it suggests that the company is consistently improving its profitability. Moving forward, investors should monitor Humana Inc’s progress to judge if their strategies and investments are paying off.

    Recent Posts

    Leave a Comment